What Medartis does

Medartis AG (SIX: MED) is a Swiss medical device company founded in 1997 and headquartered in Basel that designs, manufactures, and sells osteosynthesis implants and instruments for craniomaxillofacial (CMF), upper extremity, and lower extremity surgery. The company's product platform is organized into three lines: APTUS for upper and lower extremities (covering hand, wrist, forearm, elbow, shoulder, foot, and ankle with systems such as APTUS Hand, Distal Radius 2.5, Radius & Ulna Shaft, Proximal Humerus, Hallux, Calcaneus, and CCS cannulated compression screws), MODUS for CMF (midface, mandible, orthognathics, intermaxillary fixation, tooth stabilization), and CMX, a personalized solutions service that delivers patient-specific plates, saw guides, and drill guides via a web-based portal. Core enabling technologies include the patented TriLock multidirectional locking system (±15° screw pivoting), TriLockPlus (combined locking and compression in one step), HexaDrive self-holding screws, SpeedTip polygonal-tip screws for reduced insertion torque, Crossdrive screw heads, and 3D Mesh topologically optimized structures.

Revenue is generated predominantly through hardware sales of implants and instruments to hospitals, trauma centers, and ambulatory surgery centers via orthopedic surgeons, oral and maxillofacial surgeons, and trauma specialists. Pricing is not publicly disclosed and is negotiated institutionally. The go-to-market model combines direct wholly-owned subsidiaries in twelve priority markets (Germany, United Kingdom, Switzerland, France, Spain, United States, Austria, Poland, Japan, Australia, Brazil, and Mexico) with third-party distributor networks that extend reach to over 100 countries. FY2025 sales reached CHF 269.3 million, up 24.2% at constant exchange rates with 15.7% organic growth, and core EBITDA margin expanded to 19% from 17% the prior year (both at constant exchange rates). FY2026 is guided to 16-18% organic core sales growth with a high-teens core EBITDA margin.

The portfolio has been materially expanded through M&A: full ownership of KeriMedical in 2025 (hand joint replacement including the TOUCH CMC 1 Prosthesis, KeriFlex, KeriFix, KeriFuse), a 51% controlling stake in NeoOrtho in 2025 (together adding more than CHF 800 million of addressable market), and the completed CADskills acquisition in May 2026 (patient-specific titanium 3D printing for extremities and CMF). Earlier capital actions include the planned 2022 acquisition of U.S.-based Nextremity Solutions and a CHF 115.8 million convertible bond issuance in April 2024 to fund acquisitions. Medartis operates 12 directly staffed subsidiaries and reports 1001-5000 employees globally.

Name

Medartis

Legal name

Medartis AG

Website

https://medartis.com

Company type

Public

Founded year

1997

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Medartis is a Swiss public medical device company that develops and sells osteosynthesis implants and instruments for craniomaxillofacial and extremity surgery, serving orthopedic surgeons and hospitals across 100+ countries via APTUS, MODUS, and CMX personalized solutions.

Ownership category

akta.pro rank

Product category

Orthopedic Osteosynthesis Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Osteosynthesis implants
• Orthopedic medical devices
• Extremity fixation systems
• Craniomaxillofacial surgery plates
• Patient-specific implants

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices12 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Medartis generates revenue primarily through the sale of osteosynthesis implants, surgical instruments, and related medical devices for orthopedic and craniomaxillofacial surgery. Products include plates, screws, and personalized implants sold to hospitals and surgical centers.
2. CMX Personalized Solutions: Customized patient-specific implants and surgical planning services through the CMX platform, providing personalized solutions for complex surgical cases.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Medartis develops, manufactures, and sells osteosynthesis implants and surgical instruments for fracture fixation and reconstruction in the upper extremities, lower extremities, and craniomaxillofacial (CMF) regions. The portfolio encompasses plate-and-screw systems under the APTUS and MODUS brands, personalized patient-specific implants via the CMX platform, and hand joint replacement solutions through KeriMedical. Products are sold to hospitals, surgical centers, and orthopedic surgeons worldwide via direct subsidiaries and a distributor network across more than 100 countries.

Product overview

Medartis is a Swiss orthopedic company and global leader in innovative osteosynthesis implants for cranium and extremities. The product portfolio operates as a platform-plus-modules architecture centered around three main product lines: APTUS (upper and lower extremities), MODUS (craniomaxillofacial/CMF), and CMX (personalized custom solutions). The APTUS line includes specialized systems for hand (APTUS Hand, CMC-I Fusion, Arthrodesis, CCS), wrist (Distal Radius, Ulna Shortening), forearm (Radius Ulna Shaft), elbow (Radial Head, Olecranon, Distal Humerus, Coronoid), shoulder (Clavicle, Proximal Humerus), and foot/ankle (Hallux, Fore/Midfoot, Mid/Hindfoot, SpeedTip C, All-in-One Staple, Fusion, Calcaneus, Ankle Trauma, CCS). The MODUS CMF line covers midface, mandible, and orthognathic procedures with specialized plates and fixation systems. CMX is a personalized solutions service providing patient-specific custom implants, saw guides, and drill guides through a web-based portal workflow. The company also distributes KeriMedical hand surgery products (TOUCH, KERIFLEX, KERIFIX, KERIFUSE) and acquired CADskills for titanium 3D-printed patient-specific implants. Core enabling technologies include TriLock/TriLockPlus multidirectional locking, HexaDrive self-holding screws, SpeedTip reduced-torque screws, and Crossdrive screw systems.

Differentiator

Problem solved

Functional benefit

Brands

• APTUS: Product system brand for upper and lower extremities including Hand, Wrist, Forearm, Elbow, Shoulder systems and CCS cannulated compression screws
• MODUS
• CMX
• KeriMedical
• CADskills

Products and services

• APTUS Hand System 1.2-2.3 Plate and screw system for hand surgery, specifically designed for metacarpal and phalangeal fracture osteosynthesis and osteotomies.
• CMC-I Fusion System System for carpometacarpal (CMC-I) joint fusion, available in multiple sizes (2.0, 3.0) for hand surgery applications.
• APTUS Arthrodesis System Arthrodesis (joint fusion) plate system available in 2.0/2.3 and 2.5 sizes for wrist and hand procedures.
• Distal Radius and Distal Ulna System 2.5 Plate system for distal radius and distal ulna fracture osteosynthesis, used for one of the most common fracture types in the upper extremity.
• Radius & Ulna Shaft System 2.8 Plate and screw system for radius and ulna shaft fractures of the forearm.
• Elbow and Shoulder Implants (Radial Head 2.0, Olecranon 2.8, Distal Humerus 2.8, Coronoid 2.0, Proximal Humerus 3.5, Clavicle 2.8) Comprehensive suite of plate systems addressing radial head, olecranon, distal humerus, coronoid, proximal humerus, and clavicle fractures.
• Foot & Ankle Implants (Hallux, Fore/Midfoot, Mid/Hindfoot, SpeedTip C, All-in-One Staple, Fusion 3.5, Calcaneus, Ankle Trauma) Plate and screw systems for forefoot, midfoot, hindfoot, hallux correction, calcaneal fractures, and ankle trauma.
• MODUS 2 Midface Craniomaxillofacial plate system for midface fracture fixation and reconstruction.
• MODUS 2 Mandible Plate system for mandibular fracture fixation and reconstruction.
• MODUS 2 IMF (Intermaxillary Fixation) System for intermaxillary fixation in craniomaxillofacial surgery, used for jaw immobilization.
• MODUS 2 Orthognathics Plate system designed for orthognathic (jaw) surgery procedures.
• MODUS CFS 1.8 and MODUS BFS Craniofacial mini plate systems for small bone fixation and bone fragment stabilization in midface and alveolar procedures.
• MODUS TTS (Tooth Stabilization System) System for dental/tooth stabilization in craniomaxillofacial procedures.
• CCS (Cannulated Compression Screws) SpeedTip cannulated compression screws system for upper and lower extremity applications, enabling reduced insertion torque and compression fixation.
• CMX Personalized Solutions Platform Integrated service platform providing patient-specific custom implants, surgical guides, and drill guides for complex cases across CMF, upper extremities, and lower extremities, with web-based case management, 3D visualization, and design collaboration.
• CADskills Patient-Specific Implants Titanium 3D-printed patient-specific implant solutions for extremity and craniomaxillofacial applications, including TMJR Parametro, AMSJI, Facial Contouring Implants, and Carpitech offerings.
• KeriMedical Hand Solutions (TOUCH CMC 1 Prosthesis, KeriFlex, KeriFix, KeriFuse) Hand prosthesis and joint replacement solutions including the TOUCH CMC 1 thumb-base prosthesis, plus KeriFlex soft tissue repair, KeriFix fixation, and KeriFuse fusion devices for hand surgery.
• Sexy Nail (US Market) New intramedullary nailing product for upper extremity procedures, targeted at the US market as part of the company's extremities innovation roadmap.

Quantifiable outcome

• 24.2% revenue growth at constant exchange rates in FY2025
• +3 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered major and minor.

• CADskillsmajorStrategic or Co-development Partner · 18 May 2026Completed acquisition of CADskills, a Belgium-based specialist in patient-specific implant solutions and titanium 3D printing for extremity and craniomaxillofacial applications. Strengthens position in personalized implant solutions and additive manufacturing.
• KeriMedicalmajorStrategic or Co-development Partner · 1 January 2025Medartis gained full ownership of KeriMedical following FDA approval in 2025, expanding its addressable market. KeriMedical specializes in hand joint replacement solutions including TOUCH CMC 1 Prosthesis, KeriFlex, KeriFix, and KeriFuse products.
• NeoOrthomajorStrategic or Co-development Partner · 1 January 2025Acquired 51% controlling stake in NeoOrtho during 2025, expanding addressable market by over CHF 800 million combined with KeriMedical acquisition.
• Nextremity SolutionsmajorStrategic or Co-development Partner · 7 March 2022Planned acquisition of Nextremity Solutions, a US-based MedTech firm, to expand Medartis presence in the US extremities market. The acquisition would provide access to Nextremity's R&D capabilities, product pipeline, and industry relationships.
• KeriMedical Distribution PartnersminorChannel Partner/ Reseller/ DistributorKeriMedical products distributed by Medartis in Austria, Germany, UK, and Australia through established distribution channels.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Stryker: Global orthopedic and medical device leader with a substantial extremities and trauma fixation portfolio (e.g., Stryker's Trauma & Extremities division). Directly comparable as a competitor in upper and lower extremity plate-and-screw systems, with overlapping surgeon customers in hospitals and ASCs.
• Integra LifeSciences: US-listed medical device company with direct, material exposure to both craniomaxillofacial (CMF) fixation and extremities via its Orthopedics & Tissue Technologies segment. One of the closest mid-cap comparables to Medartis across the same procedural categories.
• Acumed: US-based orthopedic device company specializing in upper and lower extremity fracture fixation and reconstruction. Closely comparable niche focus to Medartis' APTUS line, serving similar hand/wrist/elbow/foot/ankle surgeon customers with comparable plate-and-screw technology.
• Arthrex: Privately held global leader in sports medicine and extremities, with a significant upper extremity / hand product portfolio overlapping Medartis' APTUS offering. Direct competitor for orthopedic surgeon mindshare and procedural share, particularly in hand/wrist and shoulder.

Broad incumbents

• DePuy Synthes (Johnson & Johnson): Orthopedic medtech division of J&J and the dominant global player in trauma, CMF, and extremities osteosynthesis. Comparable to Medartis in product categories (CMF plates, extremity fixation, screws) but at vastly larger scale with broader enabling-technology offerings.
• Smith & Nephew: Global medical device company with significant trauma, extremities, and orthopedic reconstruction portfolios. Overlaps with Medartis in upper/lower extremity plating and competes in trauma surgery channels; broader sports medicine and wound care businesses make it a broader incumbent rather than pure peer.
• Zimmer Biomet: One of the largest orthopedic medtech companies globally with material trauma, extremities, and CMF exposure alongside dominant joint reconstruction. Competes with Medartis in extremity plating and CMF, though Zimmer Biomet's center of gravity is joint reconstruction.

Emerging players

• CONMED: Mid-cap orthopedic and general surgery medical device company with material extremities and sports medicine exposure. Smaller and more focused than the top-four incumbents but broader than Medartis; competes in overlapping extremities segments.
• icotec Medical: Swiss-based specialist in carbon-fiber-reinforced PEEK and titanium spinal and CMF implants with 3D-printed technology. Comparable as a smaller Swiss medtech player pursuing 3D-printed patient-specific implant strategies adjacent to Medartis' CADskills acquisition.

Regional players

• Globus Medical: Orthopedic medtech player primarily centered on spine and enabling technology, with growing musculoskeletal extremities exposure through acquisitions (e.g., NuArm). Partial overlap with Medartis in extremities, though Medartis has no spine business, making Globus a tangential rather than core peer.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medartis_global
• YouTubeyoutube.com/@Medartiscom
• Facebookfacebook.com/p/Medartis-100057387410760
• LinkedInlinkedin.com/company/medartis
• Instagraminstagram.com/medartis_global

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries15 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medartis